In March, the Washington Biotechnology and Biomedical Association and Burrill & Company will together present Life Science Innovation Northwest, a conference that will bring together scientists, entrepreneurs, investors and partners, who, working together, have the ability to discover and promulgate technologies to improve the lives of people around the world.
We originally wanted to convene a meeting in Seattle because of the potential for tremendous growth in the biotech and life sciences industries in the region. But the Pacific Northwest offers so much more; renowned for being a leading and innovative region. Companies like Boeing, Costco, Microsoft, Amazon and Starbucks are just a few who call the Northwest home. Over the past several years, the Northwest has emerged as a leader in several emerging 21st century industries, becoming one of the nation’s environmental leaders, spurring startups and expansion in green technologies, as well as in the informatics, health care IT and personalized medicine. In addition, Seattle has become the nexus for global health. This fast growing sector is tackling some of the most challenging diseases known to man, many of which affect the citizens in the Northwest and around the world.
To read the full, original article click on this link: Why Biotech Innovators Are Beating a Path to Seattle | Xconomy
Author: Chris Rivera
